User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

All Publications

Displaying 1 - 25 of 62 results.

Pages

    • Journal article
    Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy
    Van Cutsem, Eric Joulain, Florence Hoff, Paulo M Mitchell, Edith Ruff, Paul Lakomý, Radek Prausová, Jana Moiseyenko, Vladimir M van Hazel, Guy Cunningham, David Arnold, Dirk Schmoll, Hans-Joachim Ten Tije, Albert J McKendrick, Joseph Kröning, Hendrik Humblet, Yves[UCL] Grávalos, Cristina Le-Guennec, Solenn Andria, Michael Dochy, Emmanuelle Vishwanath, Raghu L Macarulla, Teresa Tabernero, Josep (2016) Targeted Oncology : biotherapies for the clinicians in oncology — Vol. 11, no. 3, p. 383-400 (2016)
    • Journal article
    Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.
    Javle, Milind Lowery, Maeve Shroff, Rachna T Weiss, Karl Heinz Springfeld, Christoph Borad, Mitesh J Ramanathan, Ramesh K Goyal, Lipika Sadeghi, Saeed Macarulla, Teresa El-Khoueiry, Anthony Kelley, Robin Kate Borbath, Ivan[UCL] Choo, Su Pin Oh, Do-Youn Philip, Philip A Chen, Li-Tzong Reungwetwattana, Thanyanan Van Cutsem, Eric Yeh, Kun-Huei Ciombor, Kristen Finn, Richard S Patel, Anuradha Sen, Suman Porter, Dale Isaacs, Randi Zhu, Andrew X Abou-Alfa, Ghassan K Bekaii-Saab, Tanios (2018) Journal of Clinical Oncology — Vol. 36, p. 276-282 (2018)
    • Journal article
    Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study.
    Ajani, Jaffer El Hajbi, Farid Cunningham, David Alsina, Maria Thuss-Patience, Peter Scagliotti, Giorgio V Van den Eynde, Marc[UCL] Kim, Sung-Bae Kato, Ken Shen, Lin Li, Liyun Ding, Ningning Shi, Jingwen Barnes, Gisoo Van Cutsem, Eric (2024) ESMO open — Vol. 9, no.1, p. 102202 [1-9] (2024)
    • Speech
    Rash as a marker for the efficacy of gemcitabine plus erlotinib-based therapy in pancreatic cancer: Results from the AViTA Study
    Verslype, Chris Vervenne, Walter L Bennouna, Jaafar Humblet, Yves[UCL] Cosaert, Jan Van Cutsem, Eric (2009) 45th Annual Meeting of the American-Society-of-Clinical-Oncology — (United States) Orlando, FL
    • Journal article
    Cost-effectiveness of cetuximab in combination with irinotecan compared with current care in metastatic colorectal cancer after failure on irinotecan : A Belgian analysis
    Annemans, L. Van Cutsem, Eric Humblet, Yves[UCL] Van Laethem, Jean-Luc Bleiberg, H. (2007) Acta Clinica Belgica (Multilingual Edition) — Vol. 62, no. 6, p. 419-425 (2007)
    • Journal article
    A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial.
    Kulke, Matthew H Ruszniewski, Philippe Van Cutsem, Eric Lombard-Bohas, Catheríne Valle, Juan W De Herder, Wouter W Pavel, Marianne Degtyarev, Evgeny Brase, J C Bubuteishvili-Pacaud, Lida Voi, Maurizio Salazar, Ramón Borbath, Ivan[UCL] Fazio, Nicola Smith, Denis Capdevila, Jaume Riechelmann, Rachel Pimenta Yao, James C (2017) Annals of Oncology — Vol. 28, p. 1309-1315 (2017)
    • Journal article
    Significant impact of transient deterioration of renal function on dosimetry in PRRT.
    Van Binnebeek, Sofie Baete, Kristof Terwinghe, Christelle Vanbilloen, Bert Haustermans, Karin Mortelmans, Luc Borbath, Ivan[UCL] Van Cutsem, Eric Verslype, Chris Mottaghy, Felix M Verbruggen, Alfons Deroose, Christophe M (2012) Annals of Nuclear Medicine — Vol. 27, no.1, p. 74-77 (2012)
    • Journal article
    The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP)
    Claes, Kathleen Dahan, Karin Tejpar, S. De Paepe, Anne Bonduelle, Maryse Abramowicz, Marc Dumoulin, Christine[UCL] Franchimont, Denis Van Cutsem, Eric Kartheuser, Alex[UCL] (2011) Acta Gastro-Enterologica Belgica (Multilingual Edition) — Vol. 74, no. 3, p. 421-426 (2011)
    • Journal article
    Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
    De Roock, Wendy Piessevaux, Hubert[UCL] Jonker, Derek J. Di Nicolantonio, Federica Sartore-Bianchi, Andrea Tu, Dongsheng Siena, Salvatore Lamba, Simona Arena, Sabrina Frattini, Milo Van Cutsem, Eric[UCL] O'Callaghan, Chris J. Khambata-Ford, Shirin Zalcberg, John R. Simes, John Karapetis, Christos S. Bardelli, Alberto Tejpar, Sabine[UCL] (2010) JAMA : the journal of the American Medical Association — Vol. 304, no. 16, p. 1812-20 (2010)
    • Speech
    Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer
    Van Cutsem, Eric Peeters, Marc[UCL] Siena, Salvatore Humblet, Yves[UCL] Hendlisz, Alain Neyns, Bart Canon, Jean-Luc Van Laethem, Jean-Luc Maurel, Joan Richardson, Gary Wolf, Michael Amado, Rafael G. (2007) The 31st European Society of Medical Oncology Congress — Istanbul(Turkey)
    • Journal article
    Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab : A fluorescent in situ hybridization study
    Personeni, Nicola Fieuws, Steffen Piessevaux, Hubert[UCL] De Hertogh, Gert De Schutter, Jef Biesmans, Bart De Roock, Wendy Capoen, An Debiec-Rychter, Maria Van Laethem, Jean-Luc Peeters, Marc Humblet, Yves[UCL] Van Cutsem, Eric Tejpar, Sabine (2008) Clinical Cancer Research — Vol. 14, no. 18, p. 5869-5876 (2008)
    • Speech
    Treatment effect of panitumumab in subsets by epidermal growth factor receptor (EGFR) status from a phase 3 randomized controlled trial
    Siena, Salvatore Humblet, Yves[UCL] Van Cutsem, Eric Peeters, Marc Hendlisz, Alain Neyns, Bart Canon, Jean-Luc Van Laethem, Jean-Luc Maurel, Joan Richardson, Gary (2006) 30th Congress of the European-Society-for-Medical-Oncology — Istanbul (Turkey)
    • Journal article
    Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD.
    Schmoll, Hans-Joachim Stein, Alexander Van Cutsem, Eric Price, Timothy Hofheinz, Ralf D Nordlinger, Bernard Daisne, Jean-François[UCL] Janssens, Jos Brenner, Baruch Reinel, Hans Hollerbach, Stephan Caca, Karel Fauth, Florian Hannig, Carla V Zalcberg, John Tebbutt, Niall Mauer, Murielle E Marreaud, Sandrine Lutz, Manfred P Haustermans, Karin (2020) Journal of clinical oncology — Vol. 39, no. 1, p. 17-29 (2021)
    • Journal article
    Corrigendum to "Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?" (vol 42, pg 42, 2006)
    Efficace, Fabio Bottomley, Andrew Coens, Corneel Van Steen, Kristel Conroy, Thierry Schoeffski, Patrick Schmoll, Hans Van Cutsem, Eric[UCL] Koehne, Claus-Henning (2007) European Journal of Cancer — Vol. 43, no. 3, p. 633-633 (2007)
    • Journal article
    Molecular test algorithms for digestive tumours
    Hébrant, Aline Mourin, Anne[UCL] Froyen, Guy Van der Meulen, Joni de Man, Marc Salgado, Roberto Van den Eynde, Marc[UCL] D'haene, Nicky Martens, Geert Van Cutsem, Eric Antoine-Poirel, Hélène[UCL] Tejpar, Sabine Van Laethem, Jean-Luc Geboes, Karen Pauwels, Patrick Dedeurwaerdere, Francesca Maes, Brigitte De Greve, Jacques Vanhuysse, Jacques Peeters, Pascal Vanacker, Leen Gomez-Galdon, Maria Chintinne, Marie Hendlisz, Alain De Hertogh, Gert Sagaert, Xavier Peeters, Marc Vannuffel, Pascal Lefesvre, Pierre Vermeij, Joanna Simoens, Marc Van den Moorter, Tom Van Damme, Nancy Van den Bulcke Marc (2019) Belgian Journal of Medical Oncology — Vol. 13, no.1, p. 4-10 (2019)
    • Journal article
    Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer.
    Bulle, Ashenafi Dekervel, Jeroen Deschuttere, Lise Nittner, David Libbrecht, Louis[UCL] Janky, Rekin's Plaisance, Stéphane Topal, Baki Coosemans, An Lambrechts, Diether Van Cutsem, Eric Verslype, Chris van Pelt, Jos (2020) Translational oncology — Vol. 13, no.3, p. 100743 [1-10] (2020)
    • Speech
    Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer
    Van Cutsem, Eric Vervenne, Walter L Bennouna, Jaafar Humblet, Yves[UCL] Gill, Sharlene Van Laethem, Jean-Luc Verslype, Chris Scheithauer, Werner Shang, Aijing Cosaert, Jan Moore, Malcolm J (2009) The 44th Annual Meeting of the American Society of Clinical Oncology — (United States) Chicago, IL
    • Journal article
    Magnesium wasting associated with epidermal-growth-factor receptor-targeting antibodies in colorectal cancer: a prospective study
    Tejpar, Sabine Piessevaux, Hubert[UCL] Claes, Kathleen Piront, Patricia Hoenderop, Joost G. J. Verslype, Chris Van Cutsem, Eric[UCL] (2007) The Lancet Oncology — Vol. 8, no. 5, p. 387-394 (2007)
    • Journal article
    A Global Risk Score (GRS) to Simultaneously Predict Early and Late Tumor Recurrence Risk after Resection of Hepatocellular Carcinoma.
    Dekervel, Jeroen Popovic, Dusan van Malenstein, Hannah Windmolders, Petra Heylen, Line Libbrecht, Louis[UCL] Bulle, Ashenafi De Moor, Bart Van Cutsem, Eric Nevens, Frederik Verslype, Chris van Pelt, Jos (2016) Translational Oncology (Online) — Vol. 9, no.2, p. 139-146 (2016)
    • Journal article
    Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
    Kelly, Ronan J Ajani, Jaffer A Kuzdzal, Jaroslaw Zander, Thomas Van Cutsem, Eric Piessen, Guillaume Mendez, Guillermo Feliciano, Josephine Motoyama, Satoru Lièvre, Astrid Uronis, Hope Elimova, Elena Grootscholten, Cecile Geboes, Karen Zafar, Syed Snow, Stephanie Ko, Andrew H Feeney, Kynan Schenker, Michael Kocon, Piotr Zhang, Jenny Zhu, Lili Lei, Ming Singh, Prianka Kondo, Kaoru Cleary, James M Moehler, Markus CheckMate 577 Investigators Van den Eynde, Marc[UCL] (2021) The New England journal of medicine — Vol. 384, no.13, p. 1191-1203 (2021)
    • Journal article
    Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.
    Hendlisz, Alain Van den Eynde, Marc[UCL] Peeters, Marc Maleux, Geert Lambert, Bieke Vannoote, Jaarke De Keukeleire, Katrien Verslype, Chris Defreyne, Luc Van Cutsem, Eric Delatte, Philippe Delaunoit, Thierry Personeni, Nicola Paesmans, Marianne Van Laethem, Jean-Luc Flamen, Patrick (2010) Journal of Clinical Oncology — Vol. 28, no. 23, p. 3687-3694 (2010)
    • Journal article
    Cancer colorectal : de la prévention au traitement
    Laurent, Stéphanie Van Cutsem, Eric (2004) Medecine et Hygiene — no. 2496, p. 1800-1803 (2004)
    • Journal article
    Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study).
    Ricotta, Riccardo Verrioli, Antonella Ghezzi, Silvia Porcu, Luca Grothey, A Falcone, Alfredo Van Cutsem, Eric Argilés, Guillem Adenis, Antoine Ychou, Marc Barone, Carlo Bouché, Olivier Peeters, Marc Humblet, Yves[UCL] Mineur, Laurent Sobrero, Alberto F Hubbard, Joleen M Cremolini, Chiara Prenen, Hans Tabernero, Josep Jarraya, Hajer Mazard, Thibault Deguelte-Lardiere, Sophie Papadimitriou, Konstantinos Van den Eynde, Marc[UCL] Pastorino, Alessandro Redaelli, Daniela Bencardino, Katia Funaioli, Chiara Amatu, Alessio Carlo-Stella, Giulia Torri, Valter Sartore-Bianchi, Andrea Vanzulli, Angelo Siena, Salvatore (2017) ESMO Open — Vol. 1, no. 6, p. e000111 [1-10] (2017)
    • Speech
    Trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastroesophageal junction cancer (mGEJC): Subgroup analysis from TAGS.
    Mansoor, Wasat Arkenau, Hendrik-Tobias ALSINA, MARIA Shitara, Kohei Tejani, Mohamedtaki Abdulaziz Thuss-Patience, Peter C. Cuffe, Sinead Dvorkin, Mikhail Park, David Ando, Takayuki Van den Eynde, Marc[UCL] Beretta, Giordano D. Zaniboni, Alberto Doi, Toshihiko Tabernero, Josep Ilson, David H. Makris, Lukas McGuigan, Sandra Van Cutsem, Eric (2019) 2019 ASCO Annual Meeting I - GASTROINTESTINAL (NONCOLORECTAL) CANCER —
    • Journal article
    KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab
    De Roock, Wendy Piessevaux, Hubert[UCL] De Schutter, Jef Janssens, Marc De Hertogh, Gert Personeni, Nicola Biesmans, Bart Van Laethem, Jean-Luc Peeters, Marc Humblet, Yves[UCL] Van Cutsem, Eric Tejpar, Sabine (2008) Annals of Oncology — Vol. 19, no. 3, p. 508-515 (2008)

Pages